ms. mcclain: it was elevated? dr. califf: to the task force. which has -- ms. mcclain: did the fda raise concerns about a potential shortage even before the recall, yes or no? dr. califf: i cannot speak for before the recall, but about the time of the recall. ms. mcclain: the fda did, in fact, raise the issue to at least nine different white house officials and president biden took no action. so i would like to enter an email between the fda and nine white house staff including members of the national security council, domestic policy council and special assistant to the president for public health. >> without objection, so ordered. ms. mclean: thank you. this email dated february 17 of 2022 which is the day of the voluntary recall shows the white house in communication with the fda about the voluntary retail. mr. chairman, i would like to enter another email into the record, email dated february 20 of 2022 just three days after the voluntary recall which shows the fda chief of staff already raising concerns about an infant formula shortage and raising concerns